iRhythm & Lucem Unite for Predictive Arrhythmia Detection
Slice of Healthcare Team
08/06/2025
Key highlights
- iRhythm partners with Lucem Health to identify arrhythmias in high-risk, undiagnosed patients.
- AI-driven solution uses EHR and clinical data for early cardiac risk identification.
- Targets chronic conditions like T2D, CKD, COPD, and CAD.
- Zio® monitors provide continuous ECG tracking with actionable insights.
- Supports value-based care for integrated and accountable care organizations.
Source: GlobeNewswire
Notable Quotes
“ Together with Lucem Health, iRhythm is helping lead a new way forward in care, with the goal of reaching patients before symptoms surface and before complications arise. ”
Quentin Blackford, President and CEO at iRhythm
“ Together with iRhythm, we’re bringing predictive intelligence to healthcare’s front lines — enabling earlier action, smarter resource allocation, and better outcomes for patients. ”
Sean Cassidy, Founder and CEO at Lucem Health
Why This Matters
This partnership marks a transformative shift in healthcare from reactive diagnosis to proactive, AI-driven prediction. With arrhythmias often going undetected until severe outcomes occur, early identification in populations with chronic conditions like diabetes and COPD can reduce hospitalizations, lower costs, and improve quality of life. The collaboration aligns with the healthcare industry’s growing emphasis on value-based care, making this innovation pivotal for scalable, efficient patient management.
